[Staged treatment and follow-up of patients with yersinia infections].
Basing on the data obtained on immunopathogenetic and lipid metabolism features of intestinal yersiniosis and pseudotuberculosis in children, the authors offer variants of etiotropic and pathogenetic treatment specific for certain stages of the above diseases which are able to reduce the rate of aggravations, recurrences and complications by 10-12%. Long-term follow-up showed that unfavourable outcomes of yersiniosis are not infrequent this urging the necessity of 6-12-month follow-up of the convalescents.
A V
AV
Gordeets
S N
SN
Beniova
T A
TA
Shumatova
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D005500:Follow-Up Studies; D006801:Humans; D012008:Recurrence; D013997:Time Factors; D015009:Yersinia Infections / Q000150:complications / Q000188:drug therapy*; D015012:Yersinia pseudotuberculosis Infections / Q000188:drug therapy
D000900:Anti-Bacterial Agents
Etapnoe lechenie i dispanserizatsiia bol'nykh iersiniozami.